Tag: pyrogen testing market share

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Forecasted Market Size Figures For The Pyrogen Testing Market In 2026 And 2030?

The pyrogen testing market has witnessed substantial expansion in recent years. Forecasts indicate its size will increase from $1.91 billion in 2025 to $2.16 billion in 2026, progressing at a compound annual growth rate (CAGR) of 13.0%. Historically, this market expansion is largely due to the growth in pharmaceutical manufacturing capacity, higher production volumes of injectable drugs and vaccines, mandatory regulatory requirements for pyrogen testing, the widespread adoption of LAL-based assays, and the advancement in biologics development.

The pyrogen testing market is projected for significant expansion in the coming years. By 2030, its value is anticipated to reach $3.42 billion, demonstrating a compound annual growth rate (CAGR) of 12.2%. This growth during the forecast period is largely due to factors such as the wider acceptance of rFC and MAT assays, increased capital expenditure in biopharmaceutical research and development, the scaling up of cell and gene therapy production, a heightened emphasis on animal-free testing methodologies, and greater automation within quality control laboratories. Key developments expected over the forecast period involve a growing preference for recombinant and in vitro pyrogen tests, a notable transition away from animal-derived testing approaches, an increasing need for detection assays that are both rapid and highly sensitive, the proliferation of automated endotoxin testing equipment, and a stronger commitment to regulatory adherence in biopharmaceutical production.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

What Primary Factors Are Fueling The Expansion Of The Pyrogen Testing Market?

The rising investments in research and development (R&D) by pharmaceutical and biotechnology companies are expected to propel the growth of the pyrogen testing market going forward. This testing involves assessing drugs and biologics to ensure they are free from fever-inducing contaminants, such as endotoxins, a crucial step for safe product manufacturing. The increase in R&D spending is primarily driven by the necessity to develop advanced therapies and biologics that mandate stringent quality control and safety checks. Pyrogen testing encourages greater R&D investments by confirming the safety and regulatory compliance of new drugs and biologics, thereby empowering pharmaceutical and biotechnology firms to confidently develop innovative treatments. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures climbed from $892 billion in 2022 to $940 billion in 2023, marking a $48 billion increase. Therefore, the growing R&D investments by pharmaceutical companies are stimulating the expansion of the pyrogen testing market.

Pyrogen Testing Market Driver: Increasing Prevalence Of Infectious Diseases Boosts Demand For Pyrogen Testing

The growing occurrence of tuberculosis (TB) is anticipated to drive the future growth of the pyrogen testing market. Tuberculosis is an infectious illness caused by the bacterium Mycobacterium tuberculosis, primarily affecting the lungs but capable of spreading to other organs, and remains a leading preventable cause of death globally. The increase in TB cases is fueled by factors such as population growth, urbanization, and inadequate access to healthcare, leading to higher infection rates among vulnerable populations. Pyrogen testing supports pharmaceutical safety by guaranteeing that drugs and medical devices are free from fever-inducing contaminants, such as bacterial endotoxins, thereby protecting patients. For example, in May 2025, according to the World Health Organization (WHO), a Switzerland-based health standards organization, approximately 10.8 million people developed TB worldwide in 2023, leading to 1.25 million deaths. These statistics highlight the escalating burden of a highly infectious disease and underscore the critical need for rigorous safety testing in pharmaceutical manufacturing. Consequently, the rising incidence of TB is boosting the growth of the pyrogen testing market.

How Is The Pyrogen Testing Market Structured Across Different Market Segments?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

What Trends Are Influencing The Pyrogen Testing Market Outlook?

Who Are The Leading Firms Participating In The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Access The Complete Pyrogen Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

Which Region Stands As The Largest Contributor To The Pyrogen Testing Market?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pyrogen Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=4020&type=smp

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market 2026

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Pyrogen Testing Market Expected To Reach Based On Its 2026 Value?

The pyrogen testing market size has experienced rapid expansion in recent years. It is projected to grow from $1.91 billion in 2025 to $2.16 billion in 2026, at a compound annual growth rate (CAGR) of 13.0%. The expansion observed in the historic period can be attributed to factors such as the expansion of pharmaceutical manufacturing capacity, increased production of injectable drugs and vaccines, regulatory mandates for pyrogen testing, reliance on LAL-based assays, and the growth of biologics development.

The pyrogen testing market is anticipated to experience rapid expansion over the coming years, with expectations to reach $3.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This projected growth can be attributed to factors such as the increasing adoption of rFC and MAT assays, rising investments in biopharmaceutical research and development, the expansion of cell and gene therapy manufacturing, a growing emphasis on animal-free testing solutions, and enhanced automation in quality control laboratories. Furthermore, key trends for the forecast period include the increasing integration of recombinant and in vitro pyrogen tests, a noticeable shift away from animal-based testing methods, a rising demand for rapid and highly sensitive detection assays, the proliferation of automated endotoxin testing instruments, and an increased focus on regulatory compliance in biopharmaceutical manufacturing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

Which Important Drivers Are Guiding The Pyrogen Testing Market Growth?

The increasing financial commitments to research and development (R&D) from pharmaceutical and biotechnology firms are projected to fuel expansion in the pyrogen testing market in the coming years. Pyrogen testing involves evaluating drugs and biologics to confirm the absence of fever-causing contaminants like endotoxins, which is vital for secure product manufacturing. This growth in R&D expenditure stems from the imperative to create advanced therapies and biologics that necessitate rigorous quality control and safety checks. Pyrogen testing encourages higher R&D investments by guaranteeing the safety and regulatory adherence of new drugs and biologics, thus empowering pharmaceutical and biotechnology companies to confidently pursue innovative treatments. For example, in February 2025, as reported by the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, research and development spending in the U.S. increased from $892 billion in 2022 to $940 billion in 2023, representing a rise of $48 billion. Consequently, the escalating R&D investments by pharmaceutical enterprises are acting as a catalyst for the expansion of the pyrogen testing market.

Pyrogen Testing Market Driver: Increasing Prevalence Of Infectious Diseases Boosts Demand For Pyrogen Testing

The growing occurrence of tuberculosis (TB) is anticipated to stimulate the expansion of the pyrogen testing market in the future. Tuberculosis, an infectious condition triggered by the bacterium Mycobacterium tuberculosis, primarily impacts the lungs yet can disseminate to other organs, continuing to be a primary global cause of preventable mortality. An increase in TB infections is fueled by elements such as demographic expansion, urban development, and insufficient healthcare accessibility, contributing to elevated infection rates among susceptible groups. Pyrogen testing contributes to pharmaceutical safety by guaranteeing that medications and medical apparatus are devoid of fever-inducing substances, like bacterial endotoxins, thus safeguarding patients. As an illustration, in May 2025, data from the World Health Organization (WHO), a Switzerland-based health standards organization, indicated that in 2023, roughly 10.8 million individuals worldwide contracted TB, leading to 1.25 million fatalities. These figures underscore the escalating burden of a highly contagious illness and emphasize the vital necessity for stringent safety assessments in pharmaceutical manufacturing. Therefore, the increasing occurrence of TB is propelling the expansion of the pyrogen testing market.

How Are Segments Identified Within The Pyrogen Testing Market Segment Framework?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

What Trends Are Influencing The Evolution Of The Pyrogen Testing Market?

Leading companies in the pyrogen testing market are developing innovative products, such as sustainable monocyte activation test (MAT) systems, to advance their business offerings and expand their market reach. The monocyte activation test (MAT) System is an in vitro assay utilized for pyrogen testing within the biopharmaceutical and medical device industries. For instance, in October 2023, Lonza, a Swiss multinational manufacturing company, introduced two new rapid monocyte activation test (MAT) systems: the PyroCell MAT Rapid System and the PyroCell MAT Human Serum (HS) Rapid System. These systems, which will replace Lonza’s current MAT system kit offerings, incorporate the new PeliKine Human IL-6 Rapid ELISA Kit, minimizing hands-on time and reducing the time-to-results from two days to two hours. The new tests provide pharmaceutical manufacturers with easier, faster, and more efficient MAT testing options for product safety evaluation, while also contributing to a reduction in animal reliance.

Who Are The Companies Competing Within The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Get The Full Pyrogen Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

Which Region Is The Largest In The Pyrogen Testing Market?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pyrogen Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Market Report

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Pyrogen Testing Market At The End Of The 2026–2030 Forecast Period?

The pyrogen testing market has seen significant growth in recent years. It is anticipated to increase from $1.91 billion in 2025 to $2.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The expansion observed in the historic period is attributable to the expansion of pharmaceutical manufacturing capacity, increased production of injectable drugs and vaccines, regulatory mandates for pyrogen testing, reliance on LAL-based assays, and the growth of biologics development.

The pyrogen testing market is anticipated to experience substantial expansion over the upcoming years, with projections indicating it will reach $3.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This projected growth can be attributed to several factors, including the increasing adoption of rFC and MAT assays, a rise in investments in biopharmaceutical research and development, the expansion of cell and gene therapy manufacturing, a growing focus on animal-free testing solutions, and increased automation in quality control laboratories. Key trends expected within this forecast period involve the wider acceptance of recombinant and in vitro pyrogen tests, a noticeable shift away from animal-based testing methods, an increasing demand for rapid and high-sensitivity detection assays, the proliferation of automated endotoxin testing instruments, and a stronger emphasis on regulatory compliance in biopharmaceutical manufacturing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

Which Market Drivers Are Supporting The Expansion Of The Pyrogen Testing Market?

The growing investments in research and development (R&D) by pharmaceutical and biotechnology companies are expected to drive the expansion of the **Pyrogen Testing Market** in the future. Pyrogen testing involves assessing drugs and biologics to confirm they are free from fever-inducing substances, such as endotoxins, which is vital for safe product manufacturing. The increase in R&D expenditure is driven by the necessity to create advanced therapies and biologics that demand strict quality control and safety evaluations. Pyrogen testing encourages increased R&D investments by guaranteeing the safety and regulatory compliance of new drugs and biologics, thus enabling pharmaceutical and biotechnology firms to confidently develop innovative treatments. For example, in February 2025, according to the **National Center for Science and Engineering Statistics (NCSES)**, a **US**-based government statistical agency, **U.S.** research and development expenditures climbed from **$892 billion** in **2022** to **$940 billion** in **2023**, marking an increase of **$48 billion**. Consequently, the rising R&D investments by pharmaceutical companies are propelling the growth of the **Pyrogen Testing Market**. The increasing incidence of tuberculosis (TB) is projected to stimulate the growth of the **Pyrogen Testing Market** moving forward. Tuberculosis is an infectious illness caused by the bacterium *Mycobacterium tuberculosis*, primarily affecting the lungs but capable of spreading to other organs, and it remains a leading cause of preventable death globally. The surge in TB cases is attributed to factors such as population expansion, urbanization, and gaps in healthcare access, leading to higher infection rates in vulnerable communities. Pyrogen testing contributes to pharmaceutical safety by ensuring that drugs and medical devices are devoid of fever-inducing contaminants, like bacterial endotoxins, thereby protecting patients. For instance, in May 2025, the **World Health Organization (WHO)**, a **Switzerland**-based health standards organization, reported that in **2023**, approximately **10.8 million** people worldwide developed TB, resulting in **1.25 million** fatalities. These figures underscore the escalating burden of a highly infectious disease and emphasize the critical need for stringent safety testing in pharmaceutical production. Therefore, the rising incidence of TB is fueling the growth of the **Pyrogen Testing Market**.

What Segment Types Make Up The Pyrogen Testing Market?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

Which Trends Are Impacting The Growth Of The Pyrogen Testing Market?

Leading companies in the pyrogen testing market are engaged in developing innovative products, such as sustainable monocyte activation test (MAT) systems, to enhance their business offerings and expand market reach. The monocyte activation test (MAT) System is an in vitro assay utilized for pyrogen testing within the biopharmaceutical and medical device industries. For instance, in October 2023, Lonza, a Swiss multinational manufacturing firm, introduced two new rapid monocyte activation test (MAT) systems: the PyroCell MAT Rapid System and the PyroCell MAT Human Serum (HS) Rapid System. These systems are set to replace Lonza’s existing MAT system kit offerings and include the new PeliKine Human IL-6 Rapid ELISA Kit, which minimizes hands-on time and shortens the time-to-results from two days to two hours. The new tests offer pharmaceutical manufacturers more accessible, quicker, and more efficient MAT testing alternatives for product safety, while also contributing to reducing reliance on animal testing.

Who Are The Key Players Driving Competition In The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Read the full pyrogen testing market report here:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

How Is The Pyrogen Testing Market Distributed Across Key Geographic Regions?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pyrogen Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4020&type=smp

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Global Market Report

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Pyrogen Testing Market At The End Of The 2026–2030 Forecast Period?

The pyrogen testing market has seen significant growth in recent years. It is anticipated to increase from $1.91 billion in 2025 to $2.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The expansion observed in the historic period is attributable to the expansion of pharmaceutical manufacturing capacity, increased production of injectable drugs and vaccines, regulatory mandates for pyrogen testing, reliance on LAL-based assays, and the growth of biologics development.

The pyrogen testing market is anticipated to experience substantial expansion over the upcoming years, with projections indicating it will reach $3.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This projected growth can be attributed to several factors, including the increasing adoption of rFC and MAT assays, a rise in investments in biopharmaceutical research and development, the expansion of cell and gene therapy manufacturing, a growing focus on animal-free testing solutions, and increased automation in quality control laboratories. Key trends expected within this forecast period involve the wider acceptance of recombinant and in vitro pyrogen tests, a noticeable shift away from animal-based testing methods, an increasing demand for rapid and high-sensitivity detection assays, the proliferation of automated endotoxin testing instruments, and a stronger emphasis on regulatory compliance in biopharmaceutical manufacturing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

Which Market Drivers Are Supporting The Expansion Of The Pyrogen Testing Market?

The growing investments in research and development (R&D) by pharmaceutical and biotechnology companies are expected to drive the expansion of the **Pyrogen Testing Market** in the future. Pyrogen testing involves assessing drugs and biologics to confirm they are free from fever-inducing substances, such as endotoxins, which is vital for safe product manufacturing. The increase in R&D expenditure is driven by the necessity to create advanced therapies and biologics that demand strict quality control and safety evaluations. Pyrogen testing encourages increased R&D investments by guaranteeing the safety and regulatory compliance of new drugs and biologics, thus enabling pharmaceutical and biotechnology firms to confidently develop innovative treatments. For example, in February 2025, according to the **National Center for Science and Engineering Statistics (NCSES)**, a **US**-based government statistical agency, **U.S.** research and development expenditures climbed from **$892 billion** in **2022** to **$940 billion** in **2023**, marking an increase of **$48 billion**. Consequently, the rising R&D investments by pharmaceutical companies are propelling the growth of the **Pyrogen Testing Market**. The increasing incidence of tuberculosis (TB) is projected to stimulate the growth of the **Pyrogen Testing Market** moving forward. Tuberculosis is an infectious illness caused by the bacterium *Mycobacterium tuberculosis*, primarily affecting the lungs but capable of spreading to other organs, and it remains a leading cause of preventable death globally. The surge in TB cases is attributed to factors such as population expansion, urbanization, and gaps in healthcare access, leading to higher infection rates in vulnerable communities. Pyrogen testing contributes to pharmaceutical safety by ensuring that drugs and medical devices are devoid of fever-inducing contaminants, like bacterial endotoxins, thereby protecting patients. For instance, in May 2025, the **World Health Organization (WHO)**, a **Switzerland**-based health standards organization, reported that in **2023**, approximately **10.8 million** people worldwide developed TB, resulting in **1.25 million** fatalities. These figures underscore the escalating burden of a highly infectious disease and emphasize the critical need for stringent safety testing in pharmaceutical production. Therefore, the rising incidence of TB is fueling the growth of the **Pyrogen Testing Market**.

What Segment Types Make Up The Pyrogen Testing Market?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

Which Trends Are Impacting The Growth Of The Pyrogen Testing Market?

Leading companies in the pyrogen testing market are engaged in developing innovative products, such as sustainable monocyte activation test (MAT) systems, to enhance their business offerings and expand market reach. The monocyte activation test (MAT) System is an in vitro assay utilized for pyrogen testing within the biopharmaceutical and medical device industries. For instance, in October 2023, Lonza, a Swiss multinational manufacturing firm, introduced two new rapid monocyte activation test (MAT) systems: the PyroCell MAT Rapid System and the PyroCell MAT Human Serum (HS) Rapid System. These systems are set to replace Lonza’s existing MAT system kit offerings and include the new PeliKine Human IL-6 Rapid ELISA Kit, which minimizes hands-on time and shortens the time-to-results from two days to two hours. The new tests offer pharmaceutical manufacturers more accessible, quicker, and more efficient MAT testing alternatives for product safety, while also contributing to reducing reliance on animal testing.

Who Are The Key Players Driving Competition In The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Read the full pyrogen testing market report here:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

How Is The Pyrogen Testing Market Distributed Across Key Geographic Regions?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pyrogen Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4020&type=smp

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Global Market Report

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Pyrogen Testing Market At The End Of The 2026–2030 Forecast Period?

The pyrogen testing market has seen significant growth in recent years. It is anticipated to increase from $1.91 billion in 2025 to $2.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The expansion observed in the historic period is attributable to the expansion of pharmaceutical manufacturing capacity, increased production of injectable drugs and vaccines, regulatory mandates for pyrogen testing, reliance on LAL-based assays, and the growth of biologics development.

The pyrogen testing market is anticipated to experience substantial expansion over the upcoming years, with projections indicating it will reach $3.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This projected growth can be attributed to several factors, including the increasing adoption of rFC and MAT assays, a rise in investments in biopharmaceutical research and development, the expansion of cell and gene therapy manufacturing, a growing focus on animal-free testing solutions, and increased automation in quality control laboratories. Key trends expected within this forecast period involve the wider acceptance of recombinant and in vitro pyrogen tests, a noticeable shift away from animal-based testing methods, an increasing demand for rapid and high-sensitivity detection assays, the proliferation of automated endotoxin testing instruments, and a stronger emphasis on regulatory compliance in biopharmaceutical manufacturing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

Which Market Drivers Are Supporting The Expansion Of The Pyrogen Testing Market?

The growing investments in research and development (R&D) by pharmaceutical and biotechnology companies are expected to drive the expansion of the **Pyrogen Testing Market** in the future. Pyrogen testing involves assessing drugs and biologics to confirm they are free from fever-inducing substances, such as endotoxins, which is vital for safe product manufacturing. The increase in R&D expenditure is driven by the necessity to create advanced therapies and biologics that demand strict quality control and safety evaluations. Pyrogen testing encourages increased R&D investments by guaranteeing the safety and regulatory compliance of new drugs and biologics, thus enabling pharmaceutical and biotechnology firms to confidently develop innovative treatments. For example, in February 2025, according to the **National Center for Science and Engineering Statistics (NCSES)**, a **US**-based government statistical agency, **U.S.** research and development expenditures climbed from **$892 billion** in **2022** to **$940 billion** in **2023**, marking an increase of **$48 billion**. Consequently, the rising R&D investments by pharmaceutical companies are propelling the growth of the **Pyrogen Testing Market**. The increasing incidence of tuberculosis (TB) is projected to stimulate the growth of the **Pyrogen Testing Market** moving forward. Tuberculosis is an infectious illness caused by the bacterium *Mycobacterium tuberculosis*, primarily affecting the lungs but capable of spreading to other organs, and it remains a leading cause of preventable death globally. The surge in TB cases is attributed to factors such as population expansion, urbanization, and gaps in healthcare access, leading to higher infection rates in vulnerable communities. Pyrogen testing contributes to pharmaceutical safety by ensuring that drugs and medical devices are devoid of fever-inducing contaminants, like bacterial endotoxins, thereby protecting patients. For instance, in May 2025, the **World Health Organization (WHO)**, a **Switzerland**-based health standards organization, reported that in **2023**, approximately **10.8 million** people worldwide developed TB, resulting in **1.25 million** fatalities. These figures underscore the escalating burden of a highly infectious disease and emphasize the critical need for stringent safety testing in pharmaceutical production. Therefore, the rising incidence of TB is fueling the growth of the **Pyrogen Testing Market**.

What Segment Types Make Up The Pyrogen Testing Market?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

Which Trends Are Impacting The Growth Of The Pyrogen Testing Market?

Leading companies in the pyrogen testing market are engaged in developing innovative products, such as sustainable monocyte activation test (MAT) systems, to enhance their business offerings and expand market reach. The monocyte activation test (MAT) System is an in vitro assay utilized for pyrogen testing within the biopharmaceutical and medical device industries. For instance, in October 2023, Lonza, a Swiss multinational manufacturing firm, introduced two new rapid monocyte activation test (MAT) systems: the PyroCell MAT Rapid System and the PyroCell MAT Human Serum (HS) Rapid System. These systems are set to replace Lonza’s existing MAT system kit offerings and include the new PeliKine Human IL-6 Rapid ELISA Kit, which minimizes hands-on time and shortens the time-to-results from two days to two hours. The new tests offer pharmaceutical manufacturers more accessible, quicker, and more efficient MAT testing alternatives for product safety, while also contributing to reducing reliance on animal testing.

Who Are The Key Players Driving Competition In The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Read the full pyrogen testing market report here:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

How Is The Pyrogen Testing Market Distributed Across Key Geographic Regions?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pyrogen Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4020&type=smp

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Global Market Report

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model